Stereotaxis (STXS)

1.75 +0.02  +1.16%  May 21, 2:14PM
Add to Watchlists Create an Alert

Stereotaxis R&D Expense Quarterly:

1.479M for Dec. 31, 2012
View Full Chart

Stereotaxis R&D Expense Quarterly Chart

    Stereotaxis Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 1.479M
    Sept. 30, 2012 1.905M
    June 30, 2012 2.196M
    March 31, 2012 2.825M
    Dec. 31, 2011 2.652M
    Sept. 30, 2011 3.529M
    June 30, 2011 3.311M
    March 31, 2011 3.394M
    Dec. 31, 2010 2.648M
    Sept. 30, 2010 2.868M
    June 30, 2010 3.358M
    March 31, 2010 3.370M
    Dec. 31, 2009 4.013M
    Sept. 30, 2009 3.302M
    June 30, 2009 3.636M
    March 31, 2009 3.310M
    Dec. 31, 2008 3.562M
    Sept. 30, 2008 4.380M
       
    June 30, 2008 4.782M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    June 30, 2003 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    STXS R&D Expense Quarterly Benchmarks

    Companies
    Boston Scientific 204.00M
    Edwards Lifesciences Corporation 79.80M
    Hansen Medical 3.494M

    STXS R&D Expense Quarterly Rankings

    Overall 85th percentile
    1171 of 8002
    Sector 48th percentile
    353 of 684 in Healthcare
    Industry 44th percentile
    41 of 74 in Medical Instruments & Supplies

    STXS R&D Expense Quarterly Range, Past 5 Years

    Minimum 1.479M Dec 2012
    Maximum 4.782M Jun 2008
    Average 3.185M